COVID19 positive cases in Pakistan. by Asghar Nasir (108748)

Subjects:

New COVID-19 cases for the entire US. by Fadel M. Megahed (5125373)

Values and sources for British Columbia parameterization of the model (see Supplemental Methods and Table B in S1 Text for other jurisdictions). by Sean C. Anderson (8200143)

Fig 5 - by Sean C. Anderson (8200143)

“…<p>Observed and estimated case counts for (A) New York, (B) Florida, (C) Washington, (D) California, and (E) New Zealand. …”

Fig 3 - by Sean C. Anderson (8200143)

“…<p>(A) Observed and estimated case counts, (C) estimated prevalence, and posterior estimates for (B) <i>R</i>_0b and (D) fraction of normal contacts (<i>f</i>₂) among those distancing. …”

Models hyperparameters tuning: Heatmap of mean C-index (5-fold cross validation) of the best combination of the hyperparameters and feature selections methods; also we tune the thr... by Aamna AlShehhi (15877357)

Subjects:

A flow chart showing the reported COVID-19-positive cases amongst veterans with and without the records of serum PCT test results between March 1, 2020, and February 28, 2022. by Sujee Jeyapalina (6455642)

Absence of haptoglobin increase in the first 34 weeks of 2020 in the US cohort. by Thierry Poynard (38084)

Graph showing Covid-19 cases in Bermuda. by Adam Moore (5660614)

Stereotypical patterns and example tuning trial cases. by Gaston Sivori (22794691)

Study area– 19 provinces of southern Vietnam. by Anne-Frieda Taurel (655558)

Subjects:

Temporal distribution and phase relationship of monthly dengue incidence in relative SEA countries and Guangdong Province from 2012 to 2022. by Jiaqing Xu (8596197)

Subjects:

Epidemiological characteristics of dengue in Guangdong Province from 2012 to 2022. by Jiaqing Xu (8596197)

Subjects:

Annual distribution of penicillin susceptibility among serogroup B, C, W and Y IMD isolates in England, Wales and Northern Ireland, 2010/11 to 2018/19. by Laura Willerton (11767899)

Table 2_Evaluating the risk and risk factors of dysautonomia as a post-acute sequelae of COVID-19: a secondary analysis of a matched case–control dataset.docx by Benjamin C. Pierson (20562776)

“…</p>Results<p>We identified 619,983 COVID-19 cases (158 PASC dysautonomia) and 747,978 controls (219 non-PASC dysautonomia). …”

Table 3_Evaluating the risk and risk factors of dysautonomia as a post-acute sequelae of COVID-19: a secondary analysis of a matched case–control dataset.docx by Benjamin C. Pierson (20562776)

“…</p>Results<p>We identified 619,983 COVID-19 cases (158 PASC dysautonomia) and 747,978 controls (219 non-PASC dysautonomia). …”

Image 2_Evaluating the risk and risk factors of dysautonomia as a post-acute sequelae of COVID-19: a secondary analysis of a matched case–control dataset.jpeg by Benjamin C. Pierson (20562776)

“…</p>Results<p>We identified 619,983 COVID-19 cases (158 PASC dysautonomia) and 747,978 controls (219 non-PASC dysautonomia). …”

Image 1_Evaluating the risk and risk factors of dysautonomia as a post-acute sequelae of COVID-19: a secondary analysis of a matched case–control dataset.jpeg by Benjamin C. Pierson (20562776)

“…</p>Results<p>We identified 619,983 COVID-19 cases (158 PASC dysautonomia) and 747,978 controls (219 non-PASC dysautonomia). …”

Table 1_Evaluating the risk and risk factors of dysautonomia as a post-acute sequelae of COVID-19: a secondary analysis of a matched case–control dataset.docx by Benjamin C. Pierson (20562776)

“…</p>Results<p>We identified 619,983 COVID-19 cases (158 PASC dysautonomia) and 747,978 controls (219 non-PASC dysautonomia). …”

a-c. Dengue incidence rates (per 100,000 population) across 2,471 municipalities in for the years 2022 (a), 2023 (b), and 2024 (c), Mexico. by Oliver Mendoza-Cano (9148646)